| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |